1. Thermo Fisher to buy COVID-19 test maker Mesa Biotech — Pfizer CEO backs Biden's plan for 100 million vaccine doses in 100 days — The top 10 largest biopharma M&A deals in 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Get out while you can

Discussion in 'Exact Sciences' started by anonymous, Aug 1, 2020 at 9:34 AM.

  1. anonymous

    anonymous Guest


    I’ve got three words for you: Vaginal Tightening Device
     
  2. anonymous

    anonymous Guest

    They tried to you stupid fuck! KC wouldn't sell us down the river. He cares about what we have built and that it's a Madison based company. We made a deal where Pfizer get's a % in perpetuity, they don't need to buy us when we will pay them profits from CG forever. Get your head out of Pfizers ass!

    Pfizer can't sell devices. They sell pills. Full stop.
     
  3. anonymous

    anonymous Guest


    LOL. EVERYONE has a price. Employees are never in the equation. The koolaid is strong.
     
  4. anonymous

    anonymous Guest


    largest diagnostic launch in HISTORY!!! Without Pfizer. STFU!
     
  5. anonymous

    anonymous Guest

    That’s partly because it costs $600 per test, where most diagnostics cost about $25. Regardless, if we were so damn awesome, why partner with Pfizer? We need them way more than they need us.
     
  6. anonymous

    anonymous Guest

    You are correct. We need Pfizer. Many PMR's here work part time and complain full time.
     
  7. anonymous

    anonymous Guest

    U B stoopid. Pfizer can't sell CG? Don't act like it's rocket science. That's why we hired Pfizer, they know how to sell to medical providers and have helped many territories succeed. We flounder because of stoopid mistakes and leadership failures.
     
  8. Infernode

    Infernode new user

    Joined:
    Oct 11, 2017
    Messages:
    67
    Likes Received:
    0
    Always think carefully before any decision.
     
  9. anonymous

    anonymous Guest

    Whoooaaahhh! It really is rocket science - only kids with 18 months of phone call experience can grasp the depths of truly selling this product. These damn Pfizer reps just don’t understand the complexities of our ONE reprint we sell from. It’s just too hard for them. Ha! The arrogance of ES!!
     
  10. anonymous

    anonymous Guest

    When Epi Procolon gets Medicare approval Cologuard is DONE.
     
  11. anonymous

    anonymous Guest

    Well, you can be certain that MS isn’t looking out past next week, so we’ll have no contingency plan. Currently, we have no competition except physician habit and we can’t maintain consistent growth. God knows what will happen when we actually have competition in the market. Keeping our fingers crossed for new tests, new partnerships, and new acquisitions. Hopefully, KC will come to his senses and recognize what a massive mistake he made when hiring MS, and in turn, 1/2 of Abbvie.
     
  12. anonymous

    anonymous Guest


    Explain our success prior to Pfizer then. Please show your work. How did we ever succeed prior to the Pfizer contract? Were you here? Tell us how we all did it...
     
  13. anonymous

    anonymous Guest



    they’ll come up with a plan the week of, and the next week, and the next and the next.

    It really is going to be the beginning of the end of Cologuard. There is zero reason to order a test that only gets completed half the time when there is an in office blood draw with 100% compliance. I don’t care if the sensitivity is HALF of Cologuard and neither do providers.
     
  14. anonymous

    anonymous Guest


    What needs to be done is for Exact to come out with a more sensitive blood test.
     
  15. anonymous

    anonymous Guest


    That simply isn’t happening.
     
  16. anonymous

    anonymous Guest


    wanna bet?
     
  17. anonymous

    anonymous Guest

    You mean “tests”. boom!
     
  18. anonymous

    anonymous Guest

    Keep running your mouth douche! We will continue to prove you wrong.
     
  19. anonymous

    anonymous Guest


    spoke too soon, didn't you Chachi?
     
  20. anonymous

    anonymous Guest

    Exact Science "success" before Pfizer? What success? The product is solid, yet the market share is dismal. For CG to reach it's potential, it takes lots of volume, therefore before Pfizer, no success except getting a good product launched. Typical statement by someone that has been around too long talking about the past and how great things were. If the success were so great, why would the executive team feel a need to hire Pfizer? The early PMR's were other company rejects and are still here thinking they did something special. Laughable. Pfizer was and is still needed.